Market closedADR

GSK/$GSK

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About GSK

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Ticker

$GSK

Sector

Health Care

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Brentford, United Kingdom

Employees

70,212

Website

www.gsk.com

GSK Metrics

BasicAdvanced

$66B

44.06 $0.74

0.33 $1.53

4.52%

Price and volume

Market cap

$66B

Beta

0.33

52-week high

$45.93

52-week low

$32.55

Average daily volume

3.7M

Dividend rate

$1.53

Financial strength

Current ratio

0.806

Quick ratio

0.516

Long term debt to equity

98.446

Total debt to equity

119.371

Dividend payout ratio (TTM)

95.58%

Interest coverage (TTM)

10.83%

Management effectiveness

Return on assets (TTM)

7.24%

Return on equity (TTM)

21.85%

Valuation

Price to earnings (TTM)

44.058

Price to revenue (TTM)

3.483

Price to book

3.88

Price to tangible book (TTM)

-7.07

Price to free cash flow (TTM)

22.177

Dividend yield (TTM)

4.68%

Forward dividend yield

4.52%

Growth

Revenue change (TTM)

5.59%

Earnings per share change (TTM)

-58.92%

3-year revenue growth (CAGR)

5.91%

3-year earnings per share growth (CAGR)

-17.09%

3-year dividend per share growth (CAGR)

-15.19%

What the Analysts think about GSK

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for GSK stock.

GSK Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

GSK Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

GSK News

AllArticlesVideos

Hallucinations in AI: How GSK is addressing a critical problem in drug development

VentureBeat·6 hours ago

GSK plc (GSK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Seeking Alpha·11 hours ago

Healthcare sector poised for rebound in 2025

Yahoo Finance·1 day ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $GSK

$

Capital at risk

Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for GSK stock?

GSK (GSK) has a market cap of $66B as of January 15, 2025.

What is the P/E ratio for GSK stock?

The price to earnings (P/E) ratio for GSK (GSK) stock is 44.06 as of January 15, 2025.

Does GSK stock pay dividends?

Yes, the GSK (GSK) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $1.52889 and the yield is 4.52%. GSK has a payout ratio of 95.58% on a trailing twelve-month basis.

When is the next GSK dividend payment date?

The next GSK (GSK) dividend payment date is unconfirmed.

What is the beta indicator for GSK?

GSK (GSK) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.